Please assess the completion status of the following clinical trial:

Trial Title: Study of Minirin Melt® in Adult Patients With Nocturia

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Adult aged between 19 and 65 years~* Patients having nocturia~* Decision made to prescribe Minirin Melt according to prescription information~* Willingness and ability to provide written informed consent~Exclusion Criteria:~* When patients have habitual or psychogenic polydipsia (resulting in a urine production exceeding 40ml/kg/24hours)~* When patients have a history of known or suspected cardiac insufficiency and other conditions requiring treatment with diuresis~* When patients have moderate and severe renal insufficiency (creatinine clearance below 50ml/min)~* When patients have known hyponatremia~* When patients have secretion Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)~* When patients have hypersensitivity to the active substances or to any of the excipients

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).